The combined cough frequency/severity scoring: A new approach to cough evaluation in clinical settings

Journal of Medicine

Volumn 32, Issue 3-4, 2001, Pages 181-187

  Fisman, E Z ^a   Shapira, I ^a   Motro, M ^a   Pines, A ^a   Tenenbaum, A ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Angiotensin converting enzyme inhibitor; Aspirin; Cough

Indexed keywords

ACETYLSALICYLIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COUGHING; DISEASE SEVERITY; DRUG INDUCED DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; SCORING SYSTEM; THORAX DISEASE; TREATMENT OUTCOME;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASPIRIN; COUGH; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION;

EID: 0034800042     PISSN: 00257850     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Inhaled sodium cromoglycate in angiotensin converting enzyme inhibitor cough
2. Development of aspirin resistance in persons with ischemic stroke
3. Aspirin and other platelet-active drugs
4. Cough and angioneurotic edema associated with angiotensin - Converting enzyme inhibitor therapy. A review of the literature and pathophysiology
5. Angiotensin-converting enzyme inhibitors and their influence on inflammation, bronchial reactivity and cough. A research review
6. Thromboxane antagonism and cough induced by angiotensin-converting-enzyme-inhibitors
7. ACE inhibitor-induced cough and bronchospasm. Incidence, mechanisms and management
8. Intermediate but not low doses of aspirin can suppress enzyme inhibitors induced cough
9. High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese